Medline adds urinary management products
To augment its growing focus on infection prevention solutions, Medline announced a new distribution partnership with BioDerm Inc. to provide customers with its line of alternative urinary management devices.
Catheter-associated urinary tract infections are the fourth most common healthcare associated infection, and utilizing alternatives to Foley catheters is the best way to help avoid a CAUTI.
Starting Jan. 1, 2018, Medline based in Northfield will have exclusive distribution rights in the USA and Canada to Men's Liberty Acute, a male external catheter designed especially for the acute care market as a means of avoiding Foley catheter use by men within the appropriate patient diagnosis segment. Additionally, the company will distribute BioDerm's portfolio of urinary management devices, such as the Men's Liberty male external catheter for homecare and managed care, CathGrip family of universal securement options and other related products.
"BioDerm offers an alternative to indwelling Foley catheters to help minimize risk of infection to patients. Their products are a perfect fit in our ERASE CAUTI Comprehensive Care Solution to ensure customers have high quality tools for managing a patient's bladder condition across all diagnoses," says Sarah Dickinson, president of Medline's Urology division.
Medline has collaborated with clinical leaders in hospitals nationwide to develop an effective and easy-to-adopt process that combines clinical thinking with product and educational resources to drive CAUTI prevention goals. Men's Liberty Acute will work alongside the Medline bladder scanner to strengthen the Bladder Bundle of ERASE CAUTI and provide staff with a better alternative for managing a patient's specific bladder condition.
"We couldn't be happier with Medline, a leader in urology products and innovative solutions that reduce infection rates due to catheterization, as our partner. Thanks to Medline's vast and knowledgeable sales force, the Men's Liberty Acute product (as well as our other urology, securement and skin protection solutions) will now be more accessible to patients, thereby reducing the prevalence and associated risks of UTIs and improving their quality of life," says Gaet Tyranski, president of BioDerm.